Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum

PLSD Collaborators

doi:10.1002/ijc.33214

Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum

PLSD Collaborators

Research output: Contribution to journal › Letter › Academic › peer-review

8 Citations (Scopus)

4 Downloads (Pure)

Original language	English
Pages (from-to)	512-513
Number of pages	2
Journal	International Journal of Cancer
Volume	148
Issue number	2
DOIs	https://doi.org/10.1002/ijc.33214
Publication status	Published - 15-Jan-2021
Externally published	Yes

Keywords

Lynch syndrome
MSH2
sarcoma

Access to Document

10.1002/ijc.33214

Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrumFinal publisher's version, 196 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{290fa478a1c64d04a9d747c7ca6d46c1,

title = "Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum",

keywords = "Lynch syndrome, MSH2, sarcoma",

author = "{PLSD Collaborators} and Mev Dominguez-Valentin and Sampson, {Julian R} and P{\aa}l M{\o}ller and Sepp{\"a}l{\"a}, {Toni T}",

year = "2021",

month = jan,

day = "15",

doi = "10.1002/ijc.33214",

language = "English",

volume = "148",

pages = "512--513",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum

AU - PLSD Collaborators

AU - Dominguez-Valentin, Mev

AU - Sampson, Julian R

AU - Møller, Pål

AU - Seppälä, Toni T

PY - 2021/1/15

Y1 - 2021/1/15

KW - Lynch syndrome

KW - MSH2

KW - sarcoma

U2 - 10.1002/ijc.33214

DO - 10.1002/ijc.33214

M3 - Letter

C2 - 32783184

SN - 0020-7136

VL - 148

SP - 512

EP - 513

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 2

ER -